LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Announces Positive Results From Breztri Trials For Uncontrolled Asthma

AstraZeneca (LSE:AZN) recently announced phase III trial results for Breztri Aerosphere, its triple-combination asthma therapy, marking a milestone in improving care standards for asthma patients. This announcement comes amidst the company's robust Q1 2025 financial performance, which showed significant gains in sales, revenue, and net income. Meanwhile, the broader market rose by 1.8% last week, buoyed by positive macroeconomic indicators such as strong jobs data. AstraZeneca's share price...
AIM:TRB
AIM:TRBConsumer Services

3 UK Penny Stocks With Market Caps Under £200M

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting the interconnectedness of global economies. Amid these broader market fluctuations, investors often look toward smaller companies for potential opportunities. Penny stocks, though an outdated term, continue to intrigue as they represent smaller or newer companies that might offer a blend of affordability and growth potential when...